← Leaderboards
Annelies Van Rie
University Of North Carolina Chapel Hill
$7,008,011
Attributed
$7,185,857
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$7,185,857 · 6
By mechanism
R01$6,184,167 · 3
R21$1,001,690 · 3
Top collaborators
- Lesley Scott2 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Anthony James Hickey$6,940,027
- Lishan Su$24,513,865
Others in their field
Top investigators on “Incidence”
- Lawrence Corey · Fred Hutchinson Cancer Center$280,538,218
- David M Nathan · Massachusetts Institute Of Technology$138,375,637
- Sharon A Nachman · Johns Hopkins University$135,132,510
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$127,753,192
- James E. Gern · University Of Wisconsin-Madison$123,967,847
- John M Lachin · George Washington University$118,672,444
Research focus
IncidenceResourcesPublic Health Medicine (Field)Hiv InfectionsTuberculosisAfricaAfrica South Of The SaharaDiagnosisResistanceAcquired Immunodeficiency SyndromeRehabilitation TherapyDrug UsageSouth AfricaPeripheralTuberculosis DrugsAntiretroviral TherapyChildhoodAnti-Retroviral AgentsChildAdultInfectionEpidemiologyBaseNatural Immunosuppression
Grant awards (22)
Combining Xpert and GIS to identify areas of high tuberculosis transmission$133,269
R21 · FY2016 · AI
Combining Xpert and GIS to identify areas of high tuberculosis transmission$222,424
R21 · FY2015 · AI
Optimizing the impact of Xpert MTB/RIF on treatment outcomes of drug resistant TB$487,630
R01 · FY2014 · AI · contact PI
Optimizing the impact of Xpert MTB/RIF on treatment outcomes of drug resistant TB$523,383
R01 · FY2013 · AI · contact PI
Optimizing the impact of Xpert MTB/RIF on treatment outcomes of drug resistant TB$593,925
R01 · FY2012 · AI · contact PI
Impact of malnutrition on TB-IRIS and pharmacokinetics of TB and ARV co-treatment$464,645
R01 · FY2012 · HD · contact PI
Impact of malnutrition on TB-IRIS and pharmacokinetics of TB and ARV co-treatment$505,545
R01 · FY2011 · HD · contact PI
Impact of malnutrition on TB-IRIS and pharmacokinetics of TB and ARV co-treatment$519,217
R01 · FY2010 · HD · contact PI
Pediatric HIV-encephalopathy in DRC: effect of ART & role of compartmentalization$414,427
R01 · FY2010 · HD · contact PI
Impact of malnutrition on TB-IRIS and pharmacokinetics of TB and ARV co-treatment$519,174
R01 · FY2009 · HD · contact PI
Pediatric HIV-encephalopathy in DRC: effect of ART & role of compartmentalization$410,275
R01 · FY2009 · HD · contact PI
Impact of malnutrition on TB-IRIS and pharmacokinetics of TB and ARV co-treatment$544,824
R01 · FY2008 · HD · contact PI
Pediatric HIV-encephalopathy in DRC: effect of ART & role of compartmentalization$421,443
R01 · FY2008 · HD · contact PI
Pediatric HIV-encephalopathy in DRC: effect of ART & role of compartmentalization$445,191
R01 · FY2007 · HD · contact PI
Pediatric HIV-encephalopathy in DRC: effect of ART & role of compartmentalization$334,488
R01 · FY2006 · HD · contact PI
Social Stigma of the New Tuberculosis$122,750
R21 · FY2005 · TW
Neurodevelopment and HIV/AIDS$25,372
R21 · FY2005 · MH
Social Stigma of the New Tuberculosis$122,750
R21 · FY2004 · TW
Neurodevelopment and HIV/AIDS$106,500
R21 · FY2004 · MH
Social Stigma of the New Tuberculosis$15,000
R21 · FY2004 · TW
Social Stigma of the New Tuberculosis$134,125
R21 · FY2003 · TW
Neurodevelopment and HIV/AIDS$119,500
R21 · FY2003 · MH